• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Incidence and risk factors of infection in liver transplant recipients: A comprehensive literature review.

作者信息

Laeeq Tooba, Tun Kyaw Min, Vongsavath Tahne, Singh Aditi, Manne Vignan

机构信息

Department of Internal Medicine, University of Nevada, Las Vegas, Las Vegas, Nevada, USA.

Department of Gastroenterology, University of Nevada, Las Vegas, Las Vegas, Nevada, USA.

出版信息

Clin Liver Dis (Hoboken). 2024 Mar 14;23(1):e0131. doi: 10.1097/CLD.0000000000000131. eCollection 2024 Jan-Jun.

DOI:10.1097/CLD.0000000000000131
PMID:38487351
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10939552/
Abstract
摘要

相似文献

1
Incidence and risk factors of infection in liver transplant recipients: A comprehensive literature review.肝移植受者感染的发生率及危险因素：一项全面的文献综述。
Clin Liver Dis (Hoboken). 2024 Mar 14;23(1):e0131. doi: 10.1097/CLD.0000000000000131. eCollection 2024 Jan-Jun.
2
A multicenter study to define the epidemiology and outcomes of Clostridioides difficile infection in pediatric hematopoietic cell and solid organ transplant recipients.一项多中心研究，旨在明确儿童造血细胞和实体器官移植受者中艰难梭菌感染的流行病学和结局。
Am J Transplant. 2020 Aug;20(8):2133-2142. doi: 10.1111/ajt.15826. Epub 2020 Mar 10.
3
Clostridioides difficile infection and recurrence among 2622 solid organ transplant recipients.2622例实体器官移植受者中的艰难梭菌感染及复发情况
Transpl Infect Dis. 2019 Dec;21(6):e13184. doi: 10.1111/tid.13184. Epub 2019 Oct 11.
4
Incidence Rates and Risk Factors of Infection in Solid Organ and Hematopoietic Stem Cell Transplant Recipients.实体器官和造血干细胞移植受者感染的发病率及危险因素
Open Forum Infect Dis. 2019 Feb 19;6(4):ofz086. doi: 10.1093/ofid/ofz086. eCollection 2019 Apr.
5
Universal molecular Clostridioides difficile screening and overtreatment in solid organ transplant recipients.普遍的分子梭状芽胞杆菌艰难梭菌筛选和实体器官移植受者的过度治疗。
Transpl Infect Dis. 2020 Oct;22(5):e13375. doi: 10.1111/tid.13375. Epub 2020 Jul 1.
6
Risk Factors for Clostridioides Difficile Diarrhea In Solid Organ Transplantation Recipients.实体器官移植受者艰难梭菌腹泻的危险因素。
Transplant Proc. 2021 Dec;53(10):2826-2832. doi: 10.1016/j.transproceed.2021.09.047. Epub 2021 Nov 10.
7
The outcomes of Clostridioides difficile infection in inpatient liver transplant population.住院肝移植患者中艰难梭菌感染的结局。
Transpl Infect Dis. 2022 Feb;24(1):e13750. doi: 10.1111/tid.13750. Epub 2021 Nov 3.
8
An analysis of the outcomes of Clostridioides difficile occurring in intestinal transplant recipients requiring hospitalization.对需要住院治疗的肠道移植受者中发生的艰难梭菌感染结局的分析。
Transpl Infect Dis. 2023 Feb;25(1):e13951. doi: 10.1111/tid.13951. Epub 2023 Jan 9.
9
Implementation of routine Clostridioides difficile infection (CDI) primary prophylaxis in lung transplant recipients.在肺移植受者中实施常规艰难梭菌感染（CDI）一级预防。
Clin Transplant. 2023 Sep;37(9):e15079. doi: 10.1111/ctr.15079. Epub 2023 Jul 21.
10
Incidence and Outcomes Associated With Clostridioides difficile Infection in Solid Organ Transplant Recipients.实体器官移植受者中艰难梭菌感染的发生率和结局。
JAMA Netw Open. 2021 Dec 1;4(12):e2141089. doi: 10.1001/jamanetworkopen.2021.41089.

本文引用的文献

1
Gut-liver axis: barriers and functional circuits.肠-肝轴：屏障和功能回路。
Nat Rev Gastroenterol Hepatol. 2023 Jul;20(7):447-461. doi: 10.1038/s41575-023-00771-6. Epub 2023 Apr 21.
2
Gut dysbiosis in nonalcoholic fatty liver disease: pathogenesis, diagnosis, and therapeutic implications.非酒精性脂肪性肝病中的肠道菌群失调：发病机制、诊断和治疗意义。
Front Cell Infect Microbiol. 2022 Nov 8;12:997018. doi: 10.3389/fcimb.2022.997018. eCollection 2022.
3
Host-microbiome interactions: Gut-Liver axis and its connection with other organs.宿主-微生物组相互作用：肠道-肝脏轴及其与其他器官的联系。
NPJ Biofilms Microbiomes. 2022 Nov 1;8(1):89. doi: 10.1038/s41522-022-00352-6.
4
Gut-liver axis: Pathophysiological concepts and clinical implications.肠-肝轴：病理生理概念及临床意义。
Cell Metab. 2022 Nov 1;34(11):1700-1718. doi: 10.1016/j.cmet.2022.09.017. Epub 2022 Oct 7.
5
Intestinal Dysbiosis and Risk of Posttransplant Clostridioides difficile Infection in a Longitudinal Cohort of Liver Transplant Recipients.肠道菌群失调与肝移植受者纵向队列中难辨梭状芽孢杆菌感染的风险。
mSphere. 2022 Oct 26;7(5):e0036122. doi: 10.1128/msphere.00361-22. Epub 2022 Sep 22.
6
Prevalence and outcomes of Clostridioides difficile infection in liver transplant recipients.肝移植受者艰难梭菌感染的流行率和结局。
Transpl Infect Dis. 2022 Feb;24(1):e13758. doi: 10.1111/tid.13758. Epub 2021 Dec 7.
7
The outcomes of Clostridioides difficile infection in inpatient liver transplant population.住院肝移植患者中艰难梭菌感染的结局。
Transpl Infect Dis. 2022 Feb;24(1):e13750. doi: 10.1111/tid.13750. Epub 2021 Nov 3.
8
Bile Acids and Microbiota: Multifaceted and Versatile Regulators of the Liver-Gut Axis.胆汁酸与微生物群：肝脏-肠道轴的多面且多功能调节剂。
Int J Mol Sci. 2021 Jan 30;22(3):1397. doi: 10.3390/ijms22031397.
9
Recurrent Infection: Risk Factors, Treatment, and Prevention.反复感染：危险因素、治疗和预防。
Gut Liver. 2019 Jan 15;13(1):16-24. doi: 10.5009/gnl18071.
10
Predictors of Mortality in Cirrhosis Inpatients With Clostridium difficile Infection.艰难梭菌感染的肝硬化住院患者的死亡预测因素
J Clin Gastroenterol. 2018 Sep;52(8):747-751. doi: 10.1097/MCG.0000000000000868.